10-Q Filing

LIFECORE BIOMEDICAL, INC. DE CIK: 1005286 Q2 2012

Filing Information

Form Type	10-Q
Accession Number	`0001437749-12-000174`
Period End Date	20111130
Filing Date	20120105
Fiscal Year	2012
Fiscal Period	Q2
XBRL Instance	lndc-20111127.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 86 Income Statement 102 Cash Flow Statement 81

Balance Sheet 86 line items

Line Item	Tag	Value	Unit	Period
Allowance for doubtful accounts (in Dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$342.00K	USD	Point-in-time
Allowance for doubtful accounts (in Dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$348.00K	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.24M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$27.82M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$8.13M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.45M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$24.24M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	26.41M	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$28.12M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	25.57M	shares	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $348 and $342 at November 27, 2011 and May 29, 2011, respectively	`AccountsReceivableNetCurrent`	$21.65M	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $348 and $342 at November 27, 2011 and May 29, 2011, respectively	`AccountsReceivableNetCurrent`	$29.05M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	25.57M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	26.41M	shares	Point-in-time
Accounts receivable, related party	`AccountsReceivableRelatedPartiesCurrent`	$314.00K	USD	Point-in-time
Accounts receivable, related party	`AccountsReceivableRelatedPartiesCurrent`	$453.00K	USD	Point-in-time
Income taxes receivable	`IncomeTaxesReceivable`	$395.00K	USD	Point-in-time
Income taxes receivable	`IncomeTaxesReceivable`	$571.00K	USD	Point-in-time
Inventories, net	`InventoryNet`	$20.16M	USD	Point-in-time
Inventories, net	`InventoryNet`	$20.18M	USD	Point-in-time
Notes and advances receivable	`NotesAndLoansReceivableNetCurrent`	$5.00K	USD	Point-in-time
Notes and advances receivable	`NotesAndLoansReceivableNetCurrent`	$1.35M	USD	Point-in-time
Deferred taxes	`DeferredTaxAssetsNetCurrent`	$542.00K	USD	Point-in-time
Deferred taxes	`DeferredTaxAssetsNetCurrent`	$1.68M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$5.99M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$5.74M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$85.63M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$87.18M	USD	Point-in-time
Investment in non-public company, non-fair value	`CostMethodInvestments`	$793.00K	USD	Point-in-time
Investment in non-public company, non-fair value	`CostMethodInvestments`	$793.00K	USD	Point-in-time
Investment in non-public company, fair value	`FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue`	$15.66M	USD	Point-in-time
Investment in non-public company, fair value	`FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue`	$16.84M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$51.78M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$52.25M	USD	Point-in-time
Goodwill, net	`Goodwill`	$36.46M	USD	Point-in-time
Goodwill, net	`Goodwill`	$36.46M	USD	Point-in-time
Trademarks/tradenames, net	`IndefiniteLivedTrademarks`	$12.43M	USD	Point-in-time
Trademarks/tradenames, net	`IndefiniteLivedTrademarks`	$12.43M	USD	Point-in-time
Customer relationships, net	`FiniteLivedCustomerListsNet`	$3.21M	USD	Point-in-time
Customer relationships, net	`FiniteLivedCustomerListsNet`	$3.37M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$196.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$253.00K	USD	Point-in-time
Total Assets	`Assets`	$206.31M	USD	Point-in-time
Total Assets	`Assets`	$209.41M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$16.75M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$18.89M	USD	Point-in-time
Related party accounts payable	`AccountsPayableRelatedPartiesCurrent`	$300.00K	USD	Point-in-time
Related party accounts payable	`AccountsPayableRelatedPartiesCurrent`	$332.00K	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$3.08M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$3.38M	USD	Point-in-time
Other accrued liabilities	`OtherAccruedLiabilitiesCurrent`	$13.30M	USD	Point-in-time
Other accrued liabilities	`OtherAccruedLiabilitiesCurrent`	$3.58M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$355.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$2.66M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$4.33M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$4.33M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$30.70M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$40.59M	USD	Point-in-time
Long-term debt, less current portion	`LongTermDebtNoncurrent`	$15.50M	USD	Point-in-time
Long-term debt, less current portion	`LongTermDebtNoncurrent`	$13.17M	USD	Point-in-time
Deferred taxes	`DeferredTaxLiabilitiesNoncurrent`	$12.01M	USD	Point-in-time
Deferred taxes	`DeferredTaxLiabilitiesNoncurrent`	$11.34M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$11.05M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$1.22M	USD	Point-in-time
Total Liabilities	`Liabilities`	$68.59M	USD	Point-in-time
Total Liabilities	`Liabilities`	$66.99M	USD	Point-in-time
Common stock, $0.001 par value; 50,000,000 shares authorized; 25,565,379 and 26,405,799 shares issued and outstanding at November 27, 2011 and May 29, 2011, respectively	`CommonStockValue`	$26.00K	USD	Point-in-time
Common stock, $0.001 par value; 50,000,000 shares authorized; 25,565,379 and 26,405,799 shares issued and outstanding at November 27, 2011 and May 29, 2011, respectively	`CommonStockValue`	$27.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$119.17M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$118.69M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-235.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-267.00K	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$17.13M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$22.28M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$140.76M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$136.06M	USD	Point-in-time
Non controlling interest	`MinorityInterest`	$1.65M	USD	Point-in-time
Non controlling interest	`MinorityInterest`	$1.67M	USD	Point-in-time
Total Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$137.73M	USD	Point-in-time
Total Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$142.42M	USD	Point-in-time
Total Liabilities and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$206.31M	USD	Point-in-time
Total Liabilities and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$209.41M	USD	Point-in-time

Income Statement 102 line items

Line Item	Tag	Value	Unit	Period
Product sales	`SalesRevenueGoodsNet`	$129.98M	USD	2 Qtrs
Product sales	`SalesRevenueGoodsNet`	$67.72M	USD	1 Quarter
Product sales	`SalesRevenueGoodsNet`	$150.21M	USD	2 Qtrs
Product sales	`SalesRevenueGoodsNet`	$79.35M	USD	1 Quarter
Services revenue, related party	`RevenueFromRelatedParties`	$2.05M	USD	2 Qtrs
Services revenue, related party	`RevenueFromRelatedParties`	$805.00K	USD	1 Quarter
Services revenue, related party	`RevenueFromRelatedParties`	$1.78M	USD	2 Qtrs
Services revenue, related party	`RevenueFromRelatedParties`	$986.00K	USD	1 Quarter
License fees	`LicensesRevenue`	$1.41M	USD	1 Quarter
License fees	`LicensesRevenue`	$3.09M	USD	2 Qtrs
License fees	`LicensesRevenue`	$1.46M	USD	1 Quarter
License fees	`LicensesRevenue`	$2.88M	USD	2 Qtrs
Total revenues	`Revenues`	$135.12M	USD	2 Qtrs
Total revenues	`Revenues`	$81.57M	USD	1 Quarter
Total revenues	`Revenues`	$154.87M	USD	2 Qtrs
Total revenues	`Revenues`	$70.17M	USD	1 Quarter
Cost of product sales	`CostOfGoodsSold`	$56.48M	USD	1 Quarter
Cost of product sales	`CostOfGoodsSold`	$66.29M	USD	1 Quarter
Cost of product sales	`CostOfGoodsSold`	$107.20M	USD	2 Qtrs
Cost of product sales	`CostOfGoodsSold`	$126.29M	USD	2 Qtrs
Cost of product sales, related party	`RelatedPartyCosts`	$960.00K	USD	1 Quarter
Cost of product sales, related party	`RelatedPartyCosts`	$2.87M	USD	2 Qtrs
Cost of product sales, related party	`RelatedPartyCosts`	$1.60M	USD	1 Quarter
Cost of product sales, related party	`RelatedPartyCosts`	$2.52M	USD	2 Qtrs
Cost of services revenue	`CostOfServices`	$1.45M	USD	2 Qtrs
Cost of services revenue	`CostOfServices`	$875.00K	USD	1 Quarter
Cost of services revenue	`CostOfServices`	$1.73M	USD	2 Qtrs
Cost of services revenue	`CostOfServices`	$666.00K	USD	1 Quarter
Total cost of revenue	`CostOfRevenue`	$111.45M	USD	2 Qtrs
Total cost of revenue	`CostOfRevenue`	$130.61M	USD	2 Qtrs
Total cost of revenue	`CostOfRevenue`	$68.56M	USD	1 Quarter
Total cost of revenue	`CostOfRevenue`	$58.31M	USD	1 Quarter
Gross profit	`GrossProfit`	$11.86M	USD	1 Quarter
Gross profit	`GrossProfit`	$23.67M	USD	2 Qtrs
Gross profit	`GrossProfit`	$24.26M	USD	2 Qtrs
Gross profit	`GrossProfit`	$13.01M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.25M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.67M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$4.49M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.34M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$6.07M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$12.51M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$11.72M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$6.46M	USD	1 Quarter
Total operating costs and expenses	`OperatingExpenses`	$8.33M	USD	1 Quarter
Total operating costs and expenses	`OperatingExpenses`	$17.18M	USD	2 Qtrs
Total operating costs and expenses	`OperatingExpenses`	$16.21M	USD	2 Qtrs
Total operating costs and expenses	`OperatingExpenses`	$8.80M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$4.21M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$7.46M	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$3.53M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$7.08M	USD	2 Qtrs
Dividend income	`InvestmentIncomeDividend`	$563.00K	USD	2 Qtrs
Dividend income	`InvestmentIncomeDividend`	$281.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$117.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$81.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$157.00K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$224.00K	USD	2 Qtrs
Interest expense	`InterestExpense`	$340.00K	USD	2 Qtrs
Interest expense	`InterestExpense`	$209.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$163.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$435.00K	USD	2 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$1.09M	USD	2 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-102.00K	USD	2 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-44.00K	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$1.08M	USD	1 Quarter
Net income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$3.39M	USD	1 Quarter
Net income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$7.15M	USD	2 Qtrs
Net income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$5.49M	USD	1 Quarter
Net income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$8.55M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$2.56M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$2.05M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$1.21M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$3.16M	USD	2 Qtrs
Consolidated net income	`ProfitLoss`	$3.44M	USD	1 Quarter
Consolidated net income	`ProfitLoss`	$5.39M	USD	2 Qtrs
Consolidated net income	`ProfitLoss`	$4.58M	USD	2 Qtrs
Consolidated net income	`ProfitLoss`	$2.18M	USD	1 Quarter
Non controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$226.00K	USD	2 Qtrs
Non controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$128.00K	USD	1 Quarter
Non controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$98.00K	USD	1 Quarter
Non controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$239.00K	USD	2 Qtrs
Net income applicable to Common Stockholders	`NetIncomeLoss`	$4.36M	USD	2 Qtrs
Net income applicable to Common Stockholders	`NetIncomeLoss`	$3.34M	USD	1 Quarter
Net income applicable to Common Stockholders	`NetIncomeLoss`	$5.15M	USD	2 Qtrs
Net income applicable to Common Stockholders	`NetIncomeLoss`	$2.06M	USD	1 Quarter
Basic net income per share (in Dollars per share)	`EarningsPerShareBasic`	$0.13	USD	1 Quarter
Basic net income per share (in Dollars per share)	`EarningsPerShareBasic`	$0.08	USD	1 Quarter
Basic net income per share (in Dollars per share)	`EarningsPerShareBasic`	$0.17	USD	2 Qtrs
Basic net income per share (in Dollars per share)	`EarningsPerShareBasic`	$0.20	USD	2 Qtrs
Diluted net income per share (in Dollars per share)	`EarningsPerShareDiluted`	$0.16	USD	2 Qtrs
Diluted net income per share (in Dollars per share)	`EarningsPerShareDiluted`	$0.13	USD	1 Quarter
Diluted net income per share (in Dollars per share)	`EarningsPerShareDiluted`	$0.20	USD	2 Qtrs
Diluted net income per share (in Dollars per share)	`EarningsPerShareDiluted`	$0.08	USD	1 Quarter
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	25.89M	shares	1 Quarter
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	26.41M	shares	2 Qtrs
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	26.32M	shares	1 Quarter
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	26.15M	shares	2 Qtrs
Diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	26.40M	shares	2 Qtrs
Diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	26.56M	shares	1 Quarter
Diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	26.64M	shares	2 Qtrs
Diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	26.14M	shares	1 Quarter

Cash Flow Statement 81 line items

Line Item	Tag	Value	Unit	Period
Consolidated net income	`ProfitLoss`	$3.44M	USD	1 Quarter
Consolidated net income	`ProfitLoss`	$5.39M	USD	2 Qtrs
Consolidated net income	`ProfitLoss`	$4.58M	USD	2 Qtrs
Consolidated net income	`ProfitLoss`	$2.18M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$2.73M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$2.60M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$885.00K	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$962.00K	USD	2 Qtrs
Tax benefit from stock-based compensation expense	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$-1.58M	USD	2 Qtrs
Tax benefit from stock-based compensation expense	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$-3.38M	USD	2 Qtrs
Increase in receivable from Monsanto for guaranteed termination fee	`IncreaseDecreaseInLongTermReceivablesCurrent`	$-400.00K	USD	2 Qtrs
Increase in receivable from Monsanto for guaranteed termination fee	`IncreaseDecreaseInLongTermReceivablesCurrent`	$-400.00K	USD	2 Qtrs
Deferred taxes	`DeferredIncomeTaxExpenseBenefit`	$-463.00K	USD	2 Qtrs
Deferred taxes	`DeferredIncomeTaxExpenseBenefit`	$737.00K	USD	2 Qtrs
Change in investment in non-public company (fair market value)	`FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLossIncludedInInvestmentIncome`	$1.17M	USD	2 Qtrs
Accounts receivable, net	`IncreaseDecreaseInReceivables`	$-6.03M	USD	2 Qtrs
Accounts receivable, net	`IncreaseDecreaseInReceivables`	$-7.41M	USD	2 Qtrs
Accounts receivable, related party	`IncreaseDecreaseInDueFromRelatedParties`	$139.00K	USD	2 Qtrs
Accounts receivable, related party	`IncreaseDecreaseInDueFromRelatedParties`	$268.00K	USD	2 Qtrs
Income taxes receivable	`IncreaseDecreaseInIncomeTaxesReceivable`	$1.68M	USD	2 Qtrs
Income taxes receivable	`IncreaseDecreaseInIncomeTaxesReceivable`	$3.55M	USD	2 Qtrs
Inventories, net	`IncreaseDecreaseInInventories`	$-3.64M	USD	2 Qtrs
Inventories, net	`IncreaseDecreaseInInventories`	$-14.00K	USD	2 Qtrs
Issuance of notes and advances receivable	`IncreaseDecreaseInNotesReceivables`	$-1.59M	USD	2 Qtrs
Issuance of notes and advances receivable	`IncreaseDecreaseInNotesReceivables`	$-1.56M	USD	2 Qtrs
Collection of notes and advances receivable	`ProceedsFromCollectionOfNotesReceivable`	$240.00K	USD	2 Qtrs
Collection of notes and advances receivable	`ProceedsFromCollectionOfNotesReceivable`	$637.00K	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$652.00K	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.53M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$4.57M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.14M	USD	2 Qtrs
Related party accounts payable	`IncreaseDecreaseInAccountsPayableRelatedParties`	$-227.00K	USD	2 Qtrs
Related party accounts payable	`IncreaseDecreaseInAccountsPayableRelatedParties`	$32.00K	USD	2 Qtrs
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$104.00K	USD	2 Qtrs
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$304.00K	USD	2 Qtrs
Other accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-84.00K	USD	2 Qtrs
Other accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-16.00K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-2.30M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-2.15M	USD	2 Qtrs
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$2.07M	USD	2 Qtrs
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-742.00K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.04M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.45M	USD	2 Qtrs
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$19.07M	USD	2 Qtrs
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$41.78M	USD	2 Qtrs
Proceeds from maturities and sales of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$22.95M	USD	2 Qtrs
Proceeds from maturities and sales of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$22.61M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$846.00K	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-22.62M	USD	2 Qtrs
Repurchase of outstanding common stock	`PaymentsForRepurchaseOfCommonStock`	$1.18M	USD	2 Qtrs
Repurchase of outstanding common stock	`PaymentsForRepurchaseOfCommonStock`	$4.80M	USD	2 Qtrs
Taxes paid by Company for stock swaps and RSUs	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$49.00K	USD	2 Qtrs
Taxes paid by Company for stock swaps and RSUs	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$24.00K	USD	2 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$109.00K	USD	2 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$91.00K	USD	2 Qtrs
Tax benefit from stock-based compensation expense	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$1.58M	USD	2 Qtrs
Tax benefit from stock-based compensation expense	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$3.38M	USD	2 Qtrs
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	$1.94M	USD	2 Qtrs
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	$2.33M	USD	2 Qtrs
(Increase) decrease in other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-24.00K	USD	2 Qtrs
(Increase) decrease in other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$57.00K	USD	2 Qtrs
Payments to minority interest holders	`PaymentsOfDistributionsToAffiliates`	$257.00K	USD	2 Qtrs
Payments to minority interest holders	`PaymentsOfDistributionsToAffiliates`	$361.00K	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.82M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-4.00M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-22.37M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-3.90M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$4.24M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$27.82M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$8.13M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$5.45M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$4.24M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$27.82M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$8.13M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$5.45M	USD	Point-in-time
Income tax expense not payable	`OtherNoncashIncomeTaxExpense`	$3.38M	USD	2 Qtrs
Income tax expense not payable	`OtherNoncashIncomeTaxExpense`	$1.58M	USD	2 Qtrs
Long-term receivable from Monsanto for guaranteed termination fee	`LongtermReceivableFromMonsantoForGuaranteedTerminationFee`	$400.00K	USD	2 Qtrs
Long-term receivable from Monsanto for guaranteed termination fee	`LongtermReceivableFromMonsantoForGuaranteedTerminationFee`	$400.00K	USD	2 Qtrs
Unrealized gain (loss) from interest rate swap	`UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss`	$-152.00K	USD	2 Qtrs
Unrealized gain (loss) from interest rate swap	`UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss`	$32.00K	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.